38 Zheda Road
Hangzhou, Zhejiang 310058
China
retrospective study; antiviral therapy; COVID-19; virus clearance; SARS-CoV-2; treatment response
Influenza; Severe epidemic; Overlapping epidemics; Incidence rate; Annual change percentage; Susceptible-exposed-infectious-recovered models